SCHAUMBURG, Ill., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced the launch of its National Research Center (“NRC”) in Chengdu, China. Based in Chengdu’s Bio-Technology Park, the NRC will focus on process and method development of technically challenging specialty injectable pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.